Literature DB >> 29634275

CysLTR1 Blockage Ameliorates Liver Injury Caused by Aluminum-Overload via PI3K/AKT/mTOR-Mediated Autophagy Activation in Vivo and in Vitro.

Congli Hu1, Junqing Yang1, Qin He2, Ying Luo1, Zhihao Chen1, Lu Yang1, Honggang Yi1, Huan Li1, Hui Xia1, Dongzhi Ran1, Yang Yang1, Jiahua Zhang1, Yuke Li1, Hong Wang1.   

Abstract

Aluminum (Al) is a trivalent cation that can accumulate in animal organs, especially in the liver. We previously demonstrated that Al-overload could induce liver morphologic aberrations and dysfunction. However, the molecular mechanism underlying liver injury caused by Al-overload still remains unknown. In the present study, we investigated the relationship between leukotrienes receptors and the PI3K/AKT/mTOR pathway in Al-induced liver injury in vivo and in vitro. We demonstrated that Al-overload significantly increased the protein expression levels of CysLTR1, PI3K, AKT, mTOR, and p62, while significantly decreasing the LC3BII protein levels in rat liver; thus, suggesting that the autophagy process was inhibited in Al-overloaded rat liver. In addition, MK-571, an inhibitor of CysLTR1, effectively protected the human hepatocyte L02 cells against injury caused by Al exposure. Moreover, CysLTR1 blockage could significantly down-regulate the PI3K/AKT/mTOR pathway and activate autophagy. The effect of MK-571 on cell viability was abolished by the treatment with the autophagy inhibitor (wortmannin) but not with the autophagy agonist (rapamycin). Taken together, our results indicated that the blockage of the leukotriene receptor of CysLTR1 promotes autophagy and further reduces hepatocyte death through the PI3K/AKT/mTOR pathway inhibition. CysLTR1 thus could represent a potential target for the new drug development for chronic noninfective liver injury.

Entities:  

Keywords:  CysLTR1; PI3K/AKT/mTOR pathway; aluminum-overload; autophagy; liver injury

Mesh:

Substances:

Year:  2018        PMID: 29634275     DOI: 10.1021/acs.molpharmaceut.8b00121

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

1.  Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms.

Authors:  Hongzhao Wang; Zijian Qin; Aixia Yan
Journal:  Mol Divers       Date:  2021-02-03       Impact factor: 3.364

2.  Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury.

Authors:  Bu-Gao Zhou; Hai-Mei Zhao; Xiu-Yun Lu; Wen Zhou; Fu-Chun Liu; Xue-Ke Liu; Duan-Yong Liu
Journal:  Front Pharmacol       Date:  2018-10-23       Impact factor: 5.810

Review 3.  Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes.

Authors:  Priyanka Saha; Anupam Das Talukdar; Rajat Nath; Satyajit D Sarker; Lutfun Nahar; Jagajjit Sahu; Manabendra Dutta Choudhury
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

4.  Protective role of thymoquinone in sepsis-induced liver injury in BALB/c mice.

Authors:  Fei Wang; Xiong Lei; Yue Zhao; Qinggong Yu; Qianwei Li; Hui Zhao; Zuowei Pei
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

5.  Cysteinyl leukotriene receptor 1 modulates autophagic activity in retinal pigment epithelial cells.

Authors:  Andreas Koller; Daniela Bruckner; Ludwig Aigner; Herbert Reitsamer; Andrea Trost
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

6.  Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Authors:  Shiyun Pu; Qinhui Liu; Yanping Li; Rui Li; Tong Wu; Zijing Zhang; Cuiyuan Huang; Xuping Yang; Jinhan He
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

7.  The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.

Authors:  Julia Marschallinger; Barbara Altendorfer; Edward Rockenstein; Miriam Holztrattner; Julia Garnweidner-Raith; Nadine Pillichshammer; Iris Leister; Birgit Hutter-Paier; Katharina Strempfl; Michael S Unger; Mansoor Chishty; Thomas Felder; Mary Johnson; Johannes Attems; Eliezer Masliah; Ludwig Aigner
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

8.  Design, Synthesis, Biological Evaluation, and Molecular Modeling of 2-Difluoromethylbenzimidazole Derivatives as Potential PI3Kα Inhibitors.

Authors:  Xiangcong Wang; Moxuan Zhang; Ranran Zhu; Zhongshan Wu; Fanhong Wu; Zhonghua Wang; Yanyan Yu
Journal:  Molecules       Date:  2022-01-08       Impact factor: 4.411

Review 9.  Leukotriene Signaling as a Target in α-Synucleinopathies.

Authors:  Katharina Strempfl; Michael S Unger; Stefanie Flunkert; Andrea Trost; Herbert A Reitsamer; Birgit Hutter-Paier; Ludwig Aigner
Journal:  Biomolecules       Date:  2022-02-23

10.  Unraveling the molecular mechanisms of hyperlipidemia using integrated lncRNA and mRNA microarray data.

Authors:  Bianling Xu; Nan Wang; Xuegong Xu; Yongmin Cai
Journal:  Exp Ther Med       Date:  2021-12-20       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.